Compliance Copy Checker for DTC & Health Brands

Key facts

• Price: $19/mo
• Category: business
• Environment: chat
• Tags: compliance, FDA, FTC, supplement-brands, DTC, health-claims
• Seller: ClawHQ

What it does

Medvi got an FDA warning letter for exactly what this catches. Paste your landing page, ad copy, product description, or social post and get a redlined compliance report with FDA / FTC regulatory citations and compliant rewrites in seconds. Built for supplement brands, DTC health startups, telehealth companies, and wellness advertisers who can't afford a $500/hr regulatory attorney on retainer but know a warning letter costs infinitely more. ## What's included - **20+ violation categories flagged** — disease claims on supplements (21 CFR 101.93), unsubstantiated "clinically proven" language (FTC Section 5), before/after imagery without typical-results disclosure (16 CFR Part 255), missing structure/function disclaimers, improper competitor brand use, fake testimonial gaps, drug claims on cosmetics, weight-loss claim safe harbors, misleading "natural" / "organic" / "FDA-approved" language - **Severity tiering per violation** — Critical (warning-letter-level, fix before publishing), High (likely complaint trigger), Medium (gray-area, defensible but risky), Low (style preference, low risk) - **Exact-quote redlines** — every flagged phrase shown verbatim with the specific reason it triggers, the regulatory citation, and a compliant rewrite you can paste in directly - **Multiple copy formats** — landing pages, paid ad copy (Meta, Google, TikTok), product descriptions (Amazon, Shopify), social posts (X, Instagram, TikTok), email subject lines + body, press releases - **Industry presets** — Supplements, OTC drugs, Cosmetics, Medical devices, Telehealth, Mental wellness, CBD, Sexual wellness, Pet supplements; each preset loads the most relevant regulatory framework - **Citation library** — direct links to the relevant CFR sections, FTC guidance documents, and recent warning-letter precedents so you can read the source ## Limitations - **NOT legal advice** — generates educational analysis to help you ask better questions and catch obvious gaps; binding regulatory decisions require a licensed regulatory attorney - **Not an attorney-client relationship** — no privilege, no representation; treat output as a pre-attorney sanity check - **U.S.-FDA-FTC focused** — Health Canada, MHRA (UK), TGA (AU), and EU MDR / EFSA frameworks adapt but are not the primary rubric - **Static rulebook** — regulations change frequently; the rubric may lag current FDA / FTC guidance; cross-check before publishing - **Public-copy-only** — analyzes language you can paste; doesn't review clinical data, label artwork, or product testing protocols ## Best fit Solopreneur supplement founders, DTC health-brand marketers, telehealth ops teams, mental-wellness app copywriters, CBD operators, pet-supplement startups — any brand small enough to not have in-house regulatory but big enough that an FDA warning letter would end the company. Especially valuable in the 1-50 employee range where a warning letter triggers Amazon delisting, FB Ads suspension, and Stripe risk review simultaneously. At $19/mo, catching ONE warning-letter-grade claim per quarter is worth more than the entire annual subscription.